Provider P46-17 Addition of Drug to the Self-Administered Oncology PA with Quantity Limit Program Read More
Provider P12-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective June 4, 2018 Read More
Provider P19R1-17 New Remittance Code: OA-45 for Purchased/Referred (PRC)-Eligible Subscribers Read More
Provider P8-18 Changes to PA for Hip Arthroplasty, Hip Resurfacing and Knee Arthroplasty for Commercial and Government Programs Lines of Business Read More
Provider P54-17 Clarification to Commercial Prior Authorization Requirements for Early Intensive Behavioral Intervention (EIBI) Read More
Provider P2R1-18 Updated: New Medical Drug Prior Authorization Requirements for Voretigene Neparvovec (Luxturna) Read More
